Business

Cybin Partners with The Chopra Foundation to Bring Awareness to the Benefits of Psychedelic-Based Therapies
"The need for new and more effective treatments across the mental health spectrum is more urgent today than ever," says...
Cathie Wood and Ark Invest buying psychedelic stocks will be significant for the industry, as Wood holds a megaphone with...
The Psychedelic CEO Round Table | feat. MindMed, Cybin, Field Trip and the Psychedelic Investor Join the Psychedelic Investor and...
This week in psychedelic business news: Cybin scores another patent; another huge psychedelics conference heads to Miami; Core One Labs...
In today's episode of The Psychedelic Investor, James Hallifax interviews Dr. Ben Sessa of Awakn Life Sciences (NEO: AWKN) (OTCQB:...
Our resident Psychedelic Investor explains why this is an important moment for the psychedelics sector....
GUYS. IT HAPPENED. Cathie Wood and ARK Invest have invested in a Psychedelic Stock! Specifically, ARKG, or the ARK Genomic...
Problematic patents have serious implications for the entire psychedelics industry....
Our resident Psychedelic Investor makes the case why the psychedelic sector may yield big returns....
Friendly advice for responsibly managing speculative bets on psychedelic stocks that may rise like a phoenix or burn to the...